Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GW Pharmaceuticals PLC (NASDAQ:GWPH)

80.65
Delayed Data
As of 4:00pm ET
 -0.98 / -1.20%
Today’s Change
35.83
Today|||52-Week Range
120.94
+16.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues52.5M42.6M49.9M44.0M
 
 
 
 
 
Cost of Goods Sold134.7K448.0K1.1M3.9M
 
 
 
 
 
Depreciation And Amortization1.2M1.5M2.3M3.5M
 
 
 
 
 
 
Operating ExpensesGross Income51.2M40.6M46.5M36.6M
 
 
 
 
 
General Expenses49.5M57.0M84.4M133.5M
 
 
 
 
 
Research And Development43.7M51.0M72.2M114.1M
 
 
 
 
 
Total Operating Expenses50.8M59.0M87.8M140.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.7M-16.3M-37.9M-96.9M
 
 
 
 
 
Extraordinary Charge0.000.00---934.5K
 
 
Interest Expense On Debt1.6K99.9K101.3K115.7K
 
 
 
 
 
Other Expenses0.000.005.3M9.6M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income2.0M-16.2M-32.5M-88.0M
 
 
 
 
 
Income Taxes-2.0M-9.1M-8.2M-19.3M
 
 
 
 
 
Net Income3.9M-7.1M-24.4M-68.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS----17.5M20.5M
 
 
 
Shares To Calculate EPS Diluted----17.5M20.5M
 
 
 
 
Earnings Per ShareEPS-----$1.40-$3.35
 
 
 
EPS Diluted-----$1.40-$3.35